Hormonal
GLP-1 receptor agonists (liraglutide 3 mg and semaglutide 2.4 mg) produce significantly greater weight loss in patients with obesity compared to orlistat, with average losses of 7 kg more than control groups in meta-analyses.
If you have obesity and a related health condition (like diabetes or high blood pressure), GLP-1 medications (liraglutide or semaglutide) are significantly more effective for weight loss than older drugs like orlistat. You must combine the medication with a healthy diet and exercise. Start with the lowest dose and increase slowly to minimize stomach upset, which usually goes away.
Los resultados de ensayos y vida real demuestran que esta medicación consigue mayores pérdidas de peso que orlistat... En un metanálisis con más de 10.000 pacientes con obesidad se vio que los tratados con arGLP-1 perdían, en promedio, 7 kg más que los que integraban los grupos control.
Why this rating
Based on large-scale meta-analyses (>10,000 patients) and Phase 3 trials (SCALE, STEP), though specific long-term data for dermatological outcomes is limited.
Source
Agonistas del receptor de GLP-1 para el tratamiento de la obesidad en pacientes con dermatosis inmunomediadas
Eva Vilarrasa et al. · Actas Dermo-Sifiliográficas · 2023
DOI 10.1016/j.ad.2023.06.017
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →